Literature DB >> 8245346

Increased levels of serum neopterin and decreased production of neutrophil superoxide anions in chronic heart failure with elevated levels of tumor necrosis factor-alpha.

C J Wiedermann1, H Beimpold, M Herold, E Knapp, H Braunsteiner.   

Abstract

OBJECTIVES: The purpose of this study was to examine the role of tumor necrosis factor-alpha and tetrahydrobiopterin and superoxide anion release from neutrophils in severe chronic heart failure.
BACKGROUND: Previous studies have demonstrated elevated production of tumor necrosis factor-alpha and free radical-induced endothelial cell damage in severe heart failure.
METHODS: Plasma and serum levels of immunoreactive interleukin-1, interleukin-6, interferon-gamma, neopterin and tumor necrosis factor-alpha and the release of superoxide anions from circulating neutrophils both at basal conditions and after triggering with f-Met-Leu-Phe or phorbol 12-myristate 13-acetate were measured in 16 patients with severe heart failure and in 11 healthy control subjects.
RESULTS: Circulating levels of tumor necrosis factor-alpha and neopterin were elevated in patients with heart failure compared with values in control subjects. A significant correlation between the two was found. Basal and phorbolester-triggered release of oxygen radicals from neutrophils was not affected in patients with heart failure. However, formylpeptide-stimulated release of oxygen radicals by neutrophils was significantly reduced.
CONCLUSIONS: Suppressed neutrophil function in patients with heart failure exhibiting elevated levels of tumor necrosis-alpha factor may indicate self-protection against the deleterious effects of neutrophil-derived oxygen radicals. Through induction of tetrahydrobiopterin synthesis (as reflected by increased neopterin), tumor necrosis factor-alpha may affect nitric oxide synthesis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8245346     DOI: 10.1016/0735-1097(93)90776-w

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  14 in total

Review 1.  Activation of cytokines as a mechanism of disease progression in heart failure.

Authors:  B Bozkurt
Journal:  Ann Rheum Dis       Date:  2000-11       Impact factor: 19.103

2.  The role of nitric oxide in heart failure. Potential for pharmacological intervention.

Authors:  P Macdonald; C Schyvens; D Winlaw
Journal:  Drugs Aging       Date:  1996-06       Impact factor: 3.923

Review 3.  Chronic heart failure and the immune system.

Authors:  Daniela Mari; Federica Di Berardino; Massimo Cugno
Journal:  Clin Rev Allergy Immunol       Date:  2002-12       Impact factor: 8.667

4.  Biomarkers in the clinical management of patients with atrial fibrillation and heart failure.

Authors:  Ioanna Koniari; Eleni Artopoulou; Dimitrios Velissaris; Mark Ainslie; Virginia Mplani; Georgia Karavasili; Nicholas Kounis; Grigorios Tsigkas
Journal:  J Geriatr Cardiol       Date:  2021-11-28       Impact factor: 3.327

5.  Short-term statin therapy improves cardiac function and symptoms in patients with idiopathic dilated cardiomyopathy.

Authors:  Koichi Node; Masashi Fujita; Masafumi Kitakaze; Masatsugu Hori; James K Liao
Journal:  Circulation       Date:  2003-07-28       Impact factor: 29.690

6.  Aldosteronism and peripheral blood mononuclear cell activation: a neuroendocrine-immune interface.

Authors:  Robert A Ahokas; Kenneth J Warrington; Ivan C Gerling; Yao Sun; Linus A Wodi; Paula A Herring; Li Lu; Syamal K Bhattacharya; Arnold E Postlethwaite; Karl T Weber
Journal:  Circ Res       Date:  2003-10-23       Impact factor: 17.367

Review 7.  Biomarkers of inflammation in heart failure.

Authors:  Biykem Bozkurt; Douglas L Mann; Anita Deswal
Journal:  Heart Fail Rev       Date:  2010-07       Impact factor: 4.214

8.  Biomarker profile in stable Fontan patients.

Authors:  Anita Saraf; Christine De Staercke; Ian Everitt; Alice Haouzi; Yi-An Ko; Staci Jennings; Jonathan H Kim; Fred H Rodriguez; Andreas P Kalogeropoulos; Arshed Quyyumi; Wendy Book
Journal:  Int J Cardiol       Date:  2020-01-09       Impact factor: 4.164

9.  Usefulness of elevated urine neopterin levels in assessing cardiac dysfunction and exercise ventilation inefficiency in patients with chronic systolic heart failure.

Authors:  Zhili Shao; Renliang Zhang; Kevin Shrestha; Allen G Borowski; Andres Schuster; Akanksha Thakur; Stanley L Hazen; W H Wilson Tang
Journal:  Am J Cardiol       Date:  2014-03-18       Impact factor: 2.778

Review 10.  Insights into pathogenesis and treatment of cytokines in cardiomyopathy.

Authors:  L Vadlamani; W T Abraham
Journal:  Curr Cardiol Rep       Date:  2000-03       Impact factor: 3.955

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.